For example, the overexpression of SNCA and SIAH2 in CM patients suggests that these genes could be used to predict the likelihood of long-term neurological damage, such as epilepsy or cognitive impairment, in survivors of severe malaria [91]. This evidence concerns the gene SIAH2 and cutaneous mastocytosis.